Add to watchlist
$75.7
Last updated:06/15/2021
MRK: NYSE
Merck & Co., Inc

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health segments. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, v… Show more

Dividend yield
3.38%
$2.56 anually

3y growth is 12.73%– Yield is 51% higher than average in Health Care sector

P/E ratio
27.34x
vs. 12.06x forward

Price is 27.34x times more than EPS $2.77 which eaquals $75.7

Payout ratio
92.45%
Yearly

92.45% of earnings is used as dividends.

CASH payout ratio

Last quarter

Become our supporter to unlock all data!
Stock volatility (Beta)
past 12 months

Become our supporter to unlock all data!
MRK dividends
Payout frequency
Quarterly
Latest ex-date
06/14/2021
3y growth
12.73%
5y growth
7.48%
$0.48
$0.48
03/14/2018
$0.48
$0.48
06/14/2018
$0.48
$0.48
09/14/2018
$0.55
$0.55
12/14/2018
2018
$1.99
$0.55
$0.55
03/14/2019
$0.55
$0.55
06/14/2019
$0.55
$0.55
09/13/2019
$0.61
$0.61
12/13/2019
2019
$2.26
$0.61
$0.61
03/13/2020
$0.61
$0.61
06/12/2020
$0.61
$0.61
09/14/2020
$0.65
$0.65
12/14/2020
2020
$2.48
$0.65
$0.65
03/12/2021
$0.65
$0.65
06/14/2021
2021
So far
$1.3
Company results
Quarterly
Annual
Fundamentals
2017
2018
2019
2020
Net Income
Income minus expenses, depreciation, interest, taxes, and other expenses
2.394B
6.22B
+159.82%
9.777B
+57.19%
7.082B
-27.56%
Cashflow
Sum up money going in and out company
6.447B
10.922B
+69.41%
13.44B
+23.05%
10.253B
-23.71%
Total liabilities
All combined debts and obligations
53.303B
55.755B
+4.60%
58.396B
+4.74%
66.184B
+13.34%
Stock exposure in ETFs
ETF
Percentage of ETF
Become a premium member and see all 67 ETFs that include this stock
Company profile
CEO
Mr. Kenneth C. Frazier
Market capitalization
Mega (190.80B)
MRK price history
Loading price stock history...